Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS
· Delayed Price · Currency is USD
0.750
+0.010 (1.35%)
Dec 26, 2024, 4:00 PM EST
Fresh Tracks Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 10.87 | 10.87 | 8.68 | 26.88 | 30.12 | 7.23 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 4.5 | Upgrade
|
| Cash & Short-Term Investments | 10.87 | 10.87 | 8.68 | 26.88 | 30.12 | 11.73 | Upgrade
|
| Cash Growth | 25.21% | 25.21% | -67.71% | -10.73% | 156.76% | 45.39% | Upgrade
|
| Receivables | 0.05 | 0.05 | 0.5 | 0.13 | - | - | Upgrade
|
| Prepaid Expenses | 0.55 | 0.55 | 0.52 | 1.09 | 3.42 | 6.24 | Upgrade
|
| Other Current Assets | 0.09 | 0.09 | 0.38 | 1.5 | - | - | Upgrade
|
| Total Current Assets | 11.55 | 11.55 | 10.08 | 29.6 | 33.53 | 17.97 | Upgrade
|
| Property, Plant & Equipment | 0.03 | 0.03 | 0.12 | 0.12 | 0.1 | 0.18 | Upgrade
|
| Long-Term Accounts Receivable | - | - | 0.06 | - | - | - | Upgrade
|
| Total Assets | 11.59 | 11.59 | 10.27 | 29.72 | 33.63 | 18.14 | Upgrade
|
| Accounts Payable | 0.41 | 0.41 | 0.57 | 1.61 | 0.57 | 2.25 | Upgrade
|
| Accrued Expenses | 1.25 | 1.25 | 2.46 | 3.14 | 5.42 | 6.38 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.29 | - | Upgrade
|
| Current Portion of Leases | - | - | 0.05 | 0.07 | 0.07 | 0.08 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | - | 1.8 | Upgrade
|
| Total Current Liabilities | 1.66 | 1.66 | 3.08 | 4.81 | 6.35 | 10.5 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.15 | - | Upgrade
|
| Long-Term Leases | - | - | - | - | - | 0.07 | Upgrade
|
| Total Liabilities | 1.66 | 1.66 | 3.08 | 4.81 | 6.5 | 10.57 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.03 | 0.03 | 0.54 | 0.09 | Upgrade
|
| Additional Paid-In Capital | 182.03 | 182.03 | 173.63 | 170.25 | 132.49 | 92.5 | Upgrade
|
| Retained Earnings | -172.16 | -172.16 | -166.47 | -145.37 | -105.89 | -84.98 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | - | -0.03 | Upgrade
|
| Total Common Equity | 9.93 | 9.93 | 7.19 | 24.91 | 27.14 | 7.57 | Upgrade
|
| Shareholders' Equity | 9.93 | 9.93 | 7.19 | 24.91 | 27.14 | 7.57 | Upgrade
|
| Total Liabilities & Equity | 11.59 | 11.59 | 10.27 | 29.72 | 33.63 | 18.14 | Upgrade
|
| Total Debt | - | - | 0.05 | 0.07 | 0.51 | 0.15 | Upgrade
|
| Net Cash (Debt) | 10.87 | 10.87 | 8.63 | 26.82 | 29.6 | 11.58 | Upgrade
|
| Net Cash Growth | 25.92% | 25.92% | -67.81% | -9.42% | 155.69% | 237.75% | Upgrade
|
| Net Cash Per Share | 2.01 | 2.01 | 3.07 | 15.02 | 54.34 | 172.35 | Upgrade
|
| Filing Date Shares Outstanding | 5.97 | 5.97 | 5.91 | 2.65 | 1.49 | 0.21 | Upgrade
|
| Total Common Shares Outstanding | 5.97 | 5.97 | 3.02 | 2.65 | 1.19 | 0.19 | Upgrade
|
| Working Capital | 9.9 | 9.9 | 7.01 | 24.79 | 27.18 | 7.47 | Upgrade
|
| Book Value Per Share | 1.66 | 1.66 | 2.38 | 9.39 | 22.80 | 40.19 | Upgrade
|
| Tangible Book Value | 9.93 | 9.93 | 7.19 | 24.91 | 27.14 | 7.57 | Upgrade
|
| Tangible Book Value Per Share | 1.66 | 1.66 | 2.38 | 9.39 | 22.80 | 40.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.